Modulation of Protein Accumulation and Uses Therefore
|
- Summary
- Modulation of protein accumulation in Motor Neurone Disease
- Technology Benefits
- Endogenous method for directly controlling TDP-43 ubiquitylation.
Utilisation of endogenous pathway within neurons (ie low chance of off-target side-effects).
In-vivo data demonstrated that viral-mediated overexpression of cyclin F in mice is safe.
The first group to identify disease-causing mutations in Cyclin F in MND and FTD patients.
Significant expertise, know-how and access to valuable research tools required to develop this technology further.
- Technology Application
- Delivery of Cyclin F to neurons
Manipulating Cyclin F expression in neurons to: correct the ubiquitylation status of TDP43 and; improve the clearance of TDP43
- Detailed Technology Description
- Identified the first disease-associated E3 ubiquitin ligase (Cyclin F) that directly targets TDP43 for ubiquitylation. Abnormal ubiquitination of TDP43 contributes to its aggregation. Accordingly we find that disease-causing mutations in Cyclin F cause hyper ubiquitylation of TDP-43 and neuronal death.
Therefore we believe that over-expressing Cyclin F can prevent or slow down disease progression by modifying the function of TDP-43.
- Type of Cooperation
- Licensing or
Research Collaboration
- Application No.
- PCT/2017/051225
- ID No.
- 2016025
- Country/Region
- Australia
For more information, please click Here
